Sfoglia per RIVISTA
DISEASE MARKERS
Collezione AOU Novara

  

Items : 9

Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients. in Disease markers / Dis Markers. 2022 Apr 29;2022:1568352. doi: 10.1155/2022/1568352. eCollection 2022.

2022
AOU Alessandria
AOU Novara

Pirisi M; Avanzi GC; D'Onghia D; Mallela VR; Minisini R; Castello LM; Bellan M; Landi R; Vassia V; Pedrinelli A; Zecca E; Rizzi E; Croce A; Casciaro GF; Costanzo M; Matino E; Rizzi M; Tonello S; Lilleri D; Sainaghi PP;

Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein. in Disease markers / Dis Markers. 2022 Feb 28;2022:3528312. doi: 10.1155/2022/3528312. eCollection 2022.

2022
AOU Novara

Rizzi M; Costanzo M; Tonello S; Matino E; Casciaro FG; Croce A; Rizzi E; Zecca E; Pedrinelli A; Vassia V; Landi R; Bellan M; Castello LM; Minisini R; Mallela VR; Avanzi GC; Pirisi M; Lilleri D; Sainaghi PP;

Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19. in Disease markers / Dis Markers. 2021 May 13;2021:8863053. doi: 10.1155/2021/8863053. eCollection 2021.

2021
AOU Alessandria
ASL Vercelli
AOU Novara

Tarantino V; Smirne C; Spinoni E; Scotti L; Sciarra M; Schimmenti A; Savoia P; Saraceno M; Santagostino M; Salamina L; Roveta A; Rognoni A; Rizzi E; Rigamonti C; Re R; Percivale I; Ragazzoni L; Pau A; Pedrinelli AR; Patrucco F; Patti G; Parisini A; Paschè A; Padelli SA; Panella M; Olivieri C; Nuzzo A; Nerici I; Mussa M; et alii...

Role of the Gas6/TAM System as a Disease Marker and Potential Drug Target. in Disease markers / Dis Markers. 2021 Jan 13;2021:2854925. doi: 10.1155/2021/2854925. eCollection 2021.

2021
AOU Novara

Sainaghi PP; Bellan M; Nerviani A;

Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders. in Disease markers / Dis Markers. 2020 May 12;2020:2696173. doi: 10.1155/2020/2696173. eCollection 2020.

2020
ASL Novara
AOU Novara

Sola D; Marino P; Castello LM; Barbaglia MN; Salmi L; Minisini R; Rigamonti C; Burlone ME; Smirne C; Carriero A; Barini M; Nerviani A; Grimoldi F; Sguazzotti M; Giubertoni A; Ianniello A; Piccinino C; Dimagli A; Bellan M; Avanzi GC; Pirisi M; Sainaghi PP;

New Insights into the Role of Tyro3, Axl, and Mer Receptors in Rheumatoid Arthritis. in Disease markers / Dis Markers. 2020 Jan 19;2020:1614627. doi: 10.1155/2020/1614627. eCollection 2020.

2020
AOU Novara

Pagani S; Bellan M; Mauro D; Castello LM; Avanzi GC; Lewis MJ; Sainaghi PP; Pitzalis C; Nerviani A;

Red Cell Distribution Width and Platelet Count as Biomarkers of Pulmonary Arterial Hypertension in Patients with Connective Tissue Disorders. in Disease markers / Dis Markers. 2019 Jun 2;2019:4981982. doi: 10.1155/2019/4981982. eCollection 2019.

2019
ASL Vercelli
AOU Novara

Pirisi M; Marino P; Sola D; Smirne C; Burlone ME; Sguazzotti M; Grimoldi F; Dimagli A; Piccinino C; Giubertoni A; Bellan M; Sainaghi PP;

Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis. in Disease markers / Dis Markers. 2019 Sep 8;2019:2304931. doi: 10.1155/2019/2304931. eCollection 2019.

2019
AOU Novara

Smirne C; Rigamonti C; De Benedittis C; Sainaghi PP; Bellan M; Burlone ME; Castello LM; Avanzi GC;

Are Fusion Transcripts in Relapsed/Metastatic Head and Neck Cancer Patients Predictive of Response to Anti-EGFR Therapies? in Disease markers / Dis Markers. 2017;2017:6870614. doi: 10.1155/2017/6870614. Epub 2017 Nov 12.

2017
AOU Novara

Bossi P; Siano M; Bergamini C; Cossu Rocca M; Sponghini AP; Giannoccaro M; Tonella L; Paoli A; Marchesi E; Perrone F; Pilotti S; Locati LD; Canevari S; Licitra L; De Cecco L;